众兴菌业(002772.SZ)：预计2025年净利润同比增长134.32%—173.37%

Core Viewpoint - The company expects a significant increase in net profit for 2025, with projections indicating a growth of 134.32% to 173.37% compared to the previous year, driven by improved sales prices and increased production capacity [1] Financial Performance - The estimated net profit attributable to shareholders for 2025 is between 30 million and 35 million yuan [1] - The net profit after deducting non-recurring gains and losses is projected to be between 26.85 million and 31.85 million yuan, reflecting a growth of 192.57% to 247.06% year-on-year [1] Sales and Production Factors - The increase in net profit is primarily attributed to the stable rise in sales prices of the company's Agaricus bisporus products and the full production capacity of the Hubei base project, leading to a year-on-year increase in sales volume [1] - The sales price of enoki mushrooms saw a recovery in the second half of the year, contributing positively to the overall performance [1] Financial Costs - Financial expenses decreased by approximately 20 million yuan year-on-year due to changes in market interest rates, exchange rates, and interest capitalization [1]